Quality Improvement Clinical Trials
2 recruiting trials for Quality Improvement. Eligibility criteria explained in plain English.
TrialFinderData lists 2 Quality Improvement clinical trials drawn from ClinicalTrials.gov, all of which are currently recruiting participants.
Research is led by China-Japan Friendship Hospital (1), Fudan University (1), among the most active sponsors registered for these trials.
The most frequently studied intervention is The multifaceted interventions (other, 1 trial), followed by Routine VTE prophylaxis, evidence-based intervention Plan for the Prevention of CRBSI in ICU patients.
Track Quality Improvement trials
Subscribe for TrialFinderData updates by email. No spam, unsubscribe anytime.
Recruiting Trials
Clinical trial data sourced from the ClinicalTrials.gov registry, maintained by the National Library of Medicine. Always consult your doctor before considering any clinical trial.
CHIPs-VTE Study in Hospitalized Patients to Prevent Hospital-Acquired Venous Thromboembolism
Although pharmacologic and mechanical methods to prevent VTE are safe, effective, cost-effective, and advocated by authoritative guidelines,many studies continue to demonstrate...
Multicenter Clinical Translational Study of "ICU-NO CRBSI" Based on Improvement Science
The goal of this type of study is to construct the continuous quality promotion project "ICU-NO CRBSI(Catheter-Related Bloodstream Infection , CRBSI)" based on improvement...
Explore Other Conditions
Frequently Asked Questions
There are currently 2 clinical trials for Quality Improvement, with 2 actively recruiting participants. These include trials across all phases from early-stage Phase 1 to late-stage Phase 3.
To join a clinical trial for Quality Improvement, review the eligibility criteria on the trial detail pages, then talk to your doctor about whether a trial is right for you. Your doctor can help you evaluate the potential benefits and risks.
Phase 3 trials are large-scale studies that test whether a treatment is effective and monitor side effects. There are 0 Phase 3 trials for Quality Improvement, representing treatments closest to potential FDA approval.
Clinical trials follow strict safety protocols overseen by Institutional Review Boards (IRBs) and the FDA. Participants are monitored closely and can withdraw at any time. Always discuss risks and benefits with your healthcare provider before enrolling.
Trial data sourced from the ClinicalTrials.gov API. This site does not provide medical advice, always talk to your doctor about clinical trial participation.